tlooto
Sign up
Open AccessMedicineBiology

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

Sarah S. Kalia, Kathy Adelman, Sherri Bale, Wendy K Chung, Christine M. Eng, James P. Evans, Gail E. Herman, Sophia B. Hufnagel, Teri E. Klein, Bruce R. Korf, K. Mckelvey, K. Ormond, C. Richards, C. Vlangos, Michael Watson, Christa L. Martin, David T. Miller

2016.11.17GENETICS IN MEDICINE

DOI: 10.1038/gim.2016.190

tlooto Summary

The new process for accepting and evaluating nominations for updates to the secondary findings list is described, and the updated secondary findings minimum list includes 59 medically actionable genes recommended for return in clinical genomic sequencing.

Abstract

Abstract is not available.

Citation format

KALIA, Sarah S., et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): A policy statement of the american college of medical genetics and genomics. GENETICS IN MEDICINE, 2016, 19: 249–255.